NEU neuren pharmaceuticals limited

Ann: Annual Report to shareholders, page-6

  1. 163 Posts.
    lightbulb Created with Sketch. 23
    "The Neuren Board is currently giving careful attention to a range of possible funding and partnering options, in order to support the future plans for Rett syndrome and other indications."

    That's all I needed.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.89
Change
-0.070(0.54%)
Mkt cap ! $1.615B
Open High Low Value Volume
$12.82 $13.05 $12.70 $1.849M 143.3K

Buyers (Bids)

No. Vol. Price($)
4 149 $12.89
 

Sellers (Offers)

Price($) Vol. No.
$12.91 751 17
View Market Depth
Last trade - 12.33pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.